Progestin inhibition of cell death in human breast cancer cell lines
- 31 March 2006
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 98 (4-5), 218-227
- https://doi.org/10.1016/j.jsbmb.2005.09.008
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Duration of adjuvant tamoxifen therapy.JNCI Monographs, 2001
- Hypothesis: Progesterone Primes Breast Cancer Cells for Cross-Talk with Proliferative or Antiproliferative SignalsMolecular Endocrinology, 1999
- Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptorThe EMBO Journal, 1998
- Biphasic Regulation of Breast Cancer Cell Growth by Progesterone: Role of the Cyclin-Dependent Kinase Inhibitors, p21 and p27Kip1Molecular Endocrinology, 1997
- Progestins and antiprogestins in mammary tumour growth and metastasisHuman Reproduction, 1994
- Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.Molecular and Cellular Biology, 1991
- Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: Antagonism by insulinBreast Cancer Research and Treatment, 1989
- Progestin effects on growth in the human breast cancer cell line T-47D—Possible therapeutic implicationsBiochemical and Biophysical Research Communications, 1987
- Antiestrogenic Effect of R5020, a Synthetic Progestin in Human Breast Cancer Cells in Culture*Journal of Clinical Endocrinology & Metabolism, 1983
- Hormone dependence in breast cancerMetabolism, 1974